Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood.2022016866 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Routine extended (30 days) chemoprophylaxis for patients undergoing laparoscopic sleeve gastrectomy may reduce Portomesenteric vein thrombosis rates.
Surg Obes Relat Dis
June 2024
Department of Surgery, NYU Langone Medical Center, Bellevue Hospital Center, New York, New York.
Background: Venous thromboembolism (VTE), including Portomesenteric vein thrombosis (PMVT), is a major complication of sleeve gastrectomy (SG). We changed our practice in July 2021 to routinely discharge all SG patients postoperatively with extended chemoprophylaxis for 30 days.
Objectives: Evaluate the efficacy and safety of routine extended chemoprophylaxis compared to 2 prior timeframes using selective extended chemoprophylaxis.
Presentation of portomesenteric thrombosis after one-anastomosis gastric bypass: Case report.
Int J Surg Case Rep
October 2023
Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Rasoule-Akram Hospital, Mansouri st., Niyayesh Ave., Sattarkhan St., Tehran, Iran.
Introduction: Obesity is a serious situation that leads to non-communicable diseases like diabetes, hypertension, and others. The prevalence of obesity is growing very fast worldwide, so follow the results bariatric surgery, the most effective treatment of obesity, is increasing. Portomesentric vein thrombosis (PMVT) is one of the rare, fatal post-bariatric complications seen most commonly in sleeve gastrectomy and Roux-en-Y gastric bypass.
View Article and Find Full Text PDFAsymptomatic Idiopathic Renal Infarction Detected Incidentally on Contrast-Enhanced Computed Tomography: A Case Report.
Medicina (Kaunas)
June 2023
Department of Internal Medicine, Hyogo Prefectural Tamba Medical Center, Tamba 669-3495, Hyogo, Japan.
: Renal infarction is an extremely rare disease. Although more than 95% of cases are symptomatic, there have been no previously reported asymptomatic cases, without any abnormal blood and urine test findings. Furthermore, the efficacy of long-term treatment of idiopathic renal infarction remains unknown.
View Article and Find Full Text PDFRE: Letter to the Editor "Practical Issues with Using Direct Oral Anticoagulant After Bariatric Metabolic Surgery" Following the Publication of: "30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents PMVT Following Laparoscopic Sleeve Gastrectomy".
Obes Surg
June 2023
California Cancer Associates for Research & Excellence, 7130 N Millbrook Ave, Fresno, CA, 93720, USA.
Prolonged thromboprophylaxis with rivaroxaban after bariatric interventions: single centre experience.
Pol Przegl Chir
February 2023
Department of Surgery and Proctology and Gastrointestinal Surgery, Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.
BackgroundVenous thromboembolism (VTE) is common after bariatric surgery and extended prophylaxis is generally recommended. Low molecular weight heparin is the most commonly used agent but requires patients to be trained to self-inject and is expensive. Rivaroxaban is an oral daily formulation approved for VTE prophylaxis after orthopedic surgery.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!